The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
November 29th 2024
The combined effects of cagrilintide and semaglutide in CagriSema offer a dual approach to weight loss and glucose regulation.
Mylan Board Unanimously Rejects Unsolicited Expression of Interest from Teva
April 27th 2015Board concludes that approach grossly undervalues Mylan, includes low-quality, high-risk Teva stock, and would expose Mylan to a problematic culture and leadership with poor record of delivering shareholder value.
Read More